Contents
Contents
The Executive Health Resources False Claims Act decision allows the government to seek dismissal of a whistleblower case after joining it, even when it initially declined to take over. The dispute began with a physician’s allegations about hospital Medicare billing. The government first let the whistleblower pursue the case, then asked to end it.
The Supreme Court’s June 16, 2023 decision answered who could seek dismissal and what the court should consider.
Executive Health Resources helped hospitals bill the United States for Medicare-covered services. A physician who worked for the company brought the qui tam case, alleging that it helped hospitals charge inpatient rates for services that should have been billed as outpatient care.
That puts the billing category at the center of the allegation. The physician’s account connected the services patients received to the way hospitals charged the government for them. For someone inside hospital billing, the relevant handoff is between what the patient received, what the billing decision said and what Medicare was asked to pay.
The False Claims Act reaches those who cause false claims to be submitted, as well as those who submit them. That is why knowledge inside a business helping hospitals bill can matter alongside knowledge inside the hospital itself.
After reviewing the physician’s evidence, the government declined to take over. The whistleblower continued the case. Executive Health Resources then sought government documents and testimony, and the government’s assessment changed. It concluded that continuing the case would impose burdens greater than its potential value and asked the court to dismiss it over the whistleblower’s objection.
Yes. The Supreme Court held that the government can seek dismissal after later intervention, meaning that it joins the case. The government must give the court a sufficient reason to join later. Once the government has joined, its dismissal power applies whether it entered at the beginning or afterward.
The government and Executive Health Resources took the same position: the government could seek dismissal even without joining. The whistleblower argued that the power was available only if the government took over at the outset. The Court rejected both positions.
Joining gives the government primary responsibility for pursuing the case, including the ability to ask that it end. We assess that government role alongside the billing evidence when we work with an insider.
The Court explained why timing could not settle the question: circumstances can change and new evidence can emerge. Congress allowed the government to reassess its initial decision.
The court applies the ordinary court rule for ending a case, together with the False Claims Act’s requirement for notice and an opportunity for a hearing. The Supreme Court also directed courts to give substantial weight to the government’s judgment.
At that stage, ending the case required a judge’s order. The whistleblower’s interests belonged in that assessment. The majority expressly recognized that someone bringing a qui tam case may have committed substantial resources to it.
The decisive question was whether the government offered a reasonable explanation for why continuing the case would impose burdens that outweighed its benefits. The Court said that explanation should ordinarily carry the decision.
The government explained the expected cost of further evidence gathering and why it believed the case had little chance of succeeding. The whistleblower disputed that assessment and argued that the case could produce a substantial recovery. The Supreme Court accepted the government’s explanation and left the dismissal in place.
The company’s demands for documents and testimony had reached the same government whose money the whistleblower sought to recover. We see the awkward result: the government was weighing the value of recovering its money against the work of answering the accused company’s demands. The government wanted out.
The majority did not hold that qui tam cases violate the Constitution. It decided the government’s authority under the False Claims Act and the standard for dismissal. The separate opinions raised a further question about private people pursuing claims for the United States.
The dissent disagreed with the majority’s reading of the statute. It would have held that the government lost this dismissal power when it initially declined to take over, and would have sent the case back for consideration of constitutional questions.
The concurrence joined the majority opinion in full. It also urged the Court to consider, in an appropriate future case, arguments about the Constitution’s provisions governing executive power. The concern was whether private whistleblowers could represent the United States’ interests in court.
Government control had been part of this discussion long before the Executive Health Resources decision. A Congressional Research Service report captured the tension in 2009:
The False Claims Act is designed to allow private individuals to sue on behalf of the government, but any False Claims Act litigation takes place in the shadow of the government’s prerogatives.
Qui Tam: The False Claims Act and Related Federal Statutes, Congressional Research Service, 2009
The report described courts rejecting constitutional objections in part because the government retained sufficient control.
The distinction also matters in the later case involving Florida Medical Associates. On September 1, 2026, the Eleventh Circuit set aside a dismissal based on the theory that whistleblowers were improperly appointed federal officers. It held that they did not occupy a continuing position established by law and therefore were not officers. It sent other executive-power arguments back for consideration.
The Justice Department’s dismissal guidance, updated in September 2026, distinguishes declining a case from asking to end it. The department considers dismissal whenever it evaluates a recommendation to decline, but says dismissal will not be warranted in every declined case.
To conserve resources, the government may investigate only far enough to decide against taking over. It may not have reached a conclusion that the case lacks merit.
The department also weighs demands on government resources against the expected gain and consults the agency responsible for the program. We work through the government’s interest in the case with you, alongside what your evidence shows.
Yes. When the government declines to take over, the whistleblower can continue the qui tam case. This decision shows that the government stays in the picture even then. Our work starts with what the insider knows and what the evidence can establish.
In hospital billing, we connect the services, the claim for payment, the company’s knowledge and why the billing choice mattered to Medicare. Those are different parts of the evidence behind a false claim. A physician’s understanding of the services and a billing employee’s understanding of the claim show different parts of the same transaction. We work through those connections with you and assess how they bear on the government’s interest in the case.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know how a hospital chose inpatient rates, speak to one of our Whistleblower Experts about how those claims reached Medicare. We develop the evidence with you, bring in False Claims Act whistleblower lawyers who understand hospital billing, and stay with you to build your strongest hospital billing whistleblower case.